Synbio-tech.com - Synbio Technologies Company News Section
Synbio Technologies Information
Logan Cummins
URL: http://www.synbio-tech.com
With the breakthroughs in synthetic biology and system biology, de novo synthesized DNA and RNA molecules or variant libraries are widely used in pharmaceutical, agriculture, biofuel and biological/chemical production. As our understanding of DNA sequences (Genotype) and biological functions (Phenotype) increases, the ability to design and synthesize (Synotype) genes, genomes, pathways, and organisms by using synthetic biology techniques is also improving quickly.Synbio Tech. has created the comprehensive Synotype platforms for biological researchers to integrate the cutting edge synthetic biology techniques and bio-informatic tools into an advanced biological innovation platform.
Synbio Technologies and GSL Biotech have finalized a non-exclusive agreement allowing customers of GSL Biotech’s “SnapGene” software to order constructs directly from Synbio Technologies after having designed them in SnapGene.
Fusion Antibodies Ltd (UK) and Synbio Technologies Co. Ltd (China/USA) are excited to announce a commercial partnership to support biologic drug development in China.
Synbio Technologies, a leading international synthetic biology service company, recently announced a new partnership with ALSTEM, LLC, a US biotech company, with the aim of developing various human CRISPR-sgRNA libraries.
Synbio Technologies will attend the 13th annual Essential Protein Engineering Summit (PEGS), May 1-5, 2017, at the Seaport World Trade Center in Boston, Massachusetts.
Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, today announced that it signed a non-exclusive agreement with Synbio Technologies. The companies will partner their respective capabilities to provide customers with access to long-length genes up to 70 kilobases.
Satisfied Users & 
Approved Press Releases
